Plus Products Launches New PLUS CBDRelief Brand, Extends Portfolio of Best-Selling Cannabis Gummies

Cannabis

According to Global News Wire, Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp-branded products company in California, today announced the launch of its new PLUS CBDRelief brand into the California Adult-Use Market.

Highlights

  • PLUS enters the wellness and relief market segment with a new product launch, alongside the introduction of the PLUS CBDRelief brand.
  • The new line-up will initially include two high-CBD, low-THC gummy products specifically formulated for the wellness and relief cannabis-user.
  • Third-party market research suggests over one-third of cannabis use occasions are for relieving pain, stress, and anxiety1.

The PLUS CBDRelief brand represents a significant extension beyond PLUS’s core brand, which was the largest cannabis-infused gummies brand in California in 2019 and claimed the best-selling cannabis product in the state across all categories over the same period2.

“We have seen compelling success with our core brand and are excited to take the next step towards becoming a true portfolio of brands with the launch of PLUS CBDRelief,” said Jake Heimark, Co-founder, and CEO.

“Last year we partnered with market structure research firm, HJR Associates, and found that when consumers used cannabis, over one-third of the time it was to address pain, stress or anxiety,” stated Mr. Heimark. “This represents a massive market that appears, thus far, to have been underserved. We believe there are almost no edibles products in California designed to meet the needs of these consumers, and we’re excited to introduce products formulated specifically for that purpose.”

The two new products include a PLUS CBDRelief 9:1 Tropical Mango with 9mg of CBD and 1mg of THC per serving, and a PLUS CBDRelief 18:1 Tart Cherry with 18 mg of CBD and 1 mg of THC per serving. Specifically formulated to help reduce chronic subclinical inflammation, provide full-body relief and promote a calm state of mind, the proprietary blends mix high-quality CBD and THC to provide powerful relief. The PLUS CBDRelief product line will deliver the highest cannabinoid content per package among gummies in the California marketplace3, while also enabling precision dosing that is difficult to achieve with other form factors like tinctures.

“Research suggests that people are looking to cannabis as a holistic tool for relief4. It’s exciting to leverage rigorous science to formulate great products that enable people to help themselves.  Research on cannabis is progressing quickly and we are driving our portfolio of products with innovative science and technologies that will support our customers’ health and wellness goals,” noted Dr. Ari Mackler, PLUS’s Chief Scientific Officer.

PLUS CBDRelief products are expected to be sold in licensed retailers across California.

Read More at source: Global News Wire

Image Source: Global News Wire